王新梓, 邱溢博, 邓雨, 于思明. 维持性血液透析患者血管钙化治疗的研究进展[J]. 实用临床医药杂志, 2022, 26(22): 144-148. DOI: 10.7619/jcmp.20221784
引用本文: 王新梓, 邱溢博, 邓雨, 于思明. 维持性血液透析患者血管钙化治疗的研究进展[J]. 实用临床医药杂志, 2022, 26(22): 144-148. DOI: 10.7619/jcmp.20221784
WANG Xinzi, QIU Yibo, DENG Yu, YU Siming. Research progress of treatment of vascular calcification in patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2022, 26(22): 144-148. DOI: 10.7619/jcmp.20221784
Citation: WANG Xinzi, QIU Yibo, DENG Yu, YU Siming. Research progress of treatment of vascular calcification in patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2022, 26(22): 144-148. DOI: 10.7619/jcmp.20221784

维持性血液透析患者血管钙化治疗的研究进展

Research progress of treatment of vascular calcification in patients with maintenance hemodialysis

  • 摘要: 维持性血液透析是终末期肾脏病的重要治疗手段, 长期的血液透析治疗会引发各种并发症。血管钙化是慢性肾脏病患者常见并发症之一,在维持性血液透析患者中发生率更高,是导致血液透析患者发生心血管事件的主要原因。目前国内外治疗以控制代谢异常为主,缺少针对维持性血液透析患者血管钙化治疗方案的系统评述。本文总结了目前针对维持行血液透析患者血管钙化药物治疗和血液净化模式的研究进展和可能机制,为后期进一步研究提供参考。

     

    Abstract: Maintenance hemodialysis is an important therapeutic method for end-stage renal disease, but the long-term hemodialysis treatment will lead to various complications. Vascular calcification is one of the common complications in patients with chronic kidney disease, which has a higher incidence rate in patients with maintenance hemodialysis, and also is the main cause of cardiovascular events in hemodialysis patients. At present, the treatment at home and abroad mainly focus on the control of metabolic abnormalities, and there is a lack of systematic review on the treatment schemes for vascular calcification in patients with maintenance hemodialysis. This paper summarized the current research progress and possible mechanism on drug treatment of vascular calcification and blood purification mode for patients with maintenance hemodialysis in order to provide reference for further research in the future.

     

/

返回文章
返回